Estimating Price Trends For Pacific Biosciences of California Inc (NASDAQ: PACB)

Pacific Biosciences of California Inc (NASDAQ:PACB) does about 10.42M shares in volume on a normal day but saw 13426259 shares change hands in Friday’s trading. The company now has a market cap of 482.04M USD. Its current market price is $1.77, marking an increase of 2.91% compared to the previous close of $1.72. The 52 week high reached by this stock is $14.55 whilst the lowest price level in 52 weeks is $1.25.

Pacific Biosciences of California Inc (PACB) has a 20-day trading average at $1.6723 and the current price is -87.84% off the 52-week high compared with 41.60% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.9740 and its 200-day simple moving average is $7.1716. If we look at the stock’s price movements over the week, volatility stands at 11.88%, which increases to 14.74% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 37.45 to suggest the stock is neutral.

The consensus objective for the share price is $4.73, suggesting that the stock has a potential upside of 62.58% over the period.

Goldman also downgraded the stock to “Neutral” from Buy on April 18, 2024 at a price target of $7-$2.50. Stephens initiated its price target at $11.

Pacific Biosciences of California Inc (PACB) stock is down -3.28% over the week and -47.63% over the past month. Its price is -81.96% year-to-date and -85.14% over the past year.

To reach the target analysts have set, the stock logically needs to grow 62.58 percent from here.

The company has a return on investment of -18.90% and return on equity of -44.28%. The beta has a value of 2.00. Price to book ratio is 0.74 and price to sales ratio is 2.41.